Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 248,771 | 287,511 | 305,744 | 252,721 | 274,992 |
| Receivables | 29,047 | 31,814 | 23,790 | 32,685 | 27,035 |
| Inventories | 16,053 | 16,137 | 9,862 | 11,614 | 14,315 |
| TOTAL | $298,991 | $341,186 | $346,462 | $301,187 | $320,345 |
| Non-Current Assets | |||||
| PPE Net | 14,021 | 14,430 | 15,066 | 13,975 | 13,126 |
| Investments And Advances | 0 | 0 | 0 | 56,860 | 48,484 |
| Intangibles | 29,440 | 30,457 | 12,552 | 13,043 | 13,701 |
| Other Non-Current Assets | 21,503 | 21,857 | 22,423 | 22,768 | 22,502 |
| TOTAL | $64,964 | $66,744 | $50,041 | $106,646 | $97,813 |
| Total Assets | $363,955 | $407,930 | $396,503 | $407,833 | $418,158 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | N/A | 812 | N/A | N/A |
| Accounts payable and accrued liabilities | 93,540 | 91,268 | 90,660 | 82,929 | 59,906 |
| TOTAL | $104,921 | $103,140 | $101,042 | $103,213 | $70,602 |
| Non-Current Liabilities | |||||
| Long Term Debt | 89,419 | 88,772 | 46,564 | 46,108 | 58,698 |
| Deferred Revenues | 1,457 | 2,034 | 2,611 | 3,354 | 4,800 |
| Other Non-Current Liabilities | 54,487 | 56,158 | 59,963 | 71,124 | 61,413 |
| TOTAL | $111,332 | $111,212 | $69,584 | $92,152 | $99,255 |
| Total Liabilities | $216,253 | $214,352 | $170,626 | $195,365 | $169,857 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,186 | 7,164 | 6,970 | 6,645 | 6,741 |
| Common Shares | 108 | 106 | 101 | 464 | 360 |
| Retained earnings | -584,579 | -563,223 | -547,463 | -515,898 | -495,117 |
| Other shareholders' equity | 70,479 | 95,719 | 117,203 | 119,810 | 140,020 |
| TOTAL | $147,702 | $193,578 | $225,877 | $212,468 | $248,301 |
| Total Liabilities And Equity | $363,955 | $407,930 | $396,503 | $407,833 | $418,158 |